Momenta Pharma (MNTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -98,600 | -108,408 | -58,648 | 180,356 | 37,290 |
| Depreciation Amortization | 10,860 | 11,744 | 10,768 | 7,192 | 5,553 |
| Accounts receivable | 6,172 | -2,284 | 17,360 | 26,314 | -54,485 |
| Accounts payable and accrued liabilities | 1,126 | 2,727 | -1,129 | 315 | 169 |
| Other Working Capital | 8,978 | -3,257 | 43,148 | 10,301 | -54,842 |
| Other Operating Activity | 6,296 | 12,646 | -2,500 | -10,753 | 65,258 |
| Operating Cash Flow | $-65,168 | $-86,832 | $8,999 | $213,725 | $-1,057 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 83,533 | 68,036 | 8,484 | -248,857 | 20,736 |
| PPE Investments | -8,360 | -9,450 | -15,491 | -8,699 | -1,671 |
| Net Acquisitions | N/A | N/A | N/A | -4,500 | N/A |
| Purchase Of Investment | N/A | N/A | -400 | 0 | 0 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -6,664 | 0 |
| Other Investing Activity | 0 | 0 | 0 | -6,664 | 0 |
| Investing Cash Flow | $75,173 | $58,586 | $-7,407 | $-268,720 | $19,065 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -1,729 | -2,344 |
| Common Stock Issued | 21,578 | 5,022 | 2,153 | 5,546 | 63,820 |
| Other Financing Activity | 0 | 0 | 0 | -258 | -737 |
| Financing Cash Flow | $21,578 | $5,022 | $2,153 | $3,559 | $60,739 |
| Beginning Cash Position | 29,766 | 52,990 | 49,245 | 100,681 | 21,934 |
| End Cash Position | 61,349 | 29,766 | 52,990 | 49,245 | 100,681 |
| Net Cash Flow | $31,583 | $-23,224 | $3,745 | $-51,436 | $78,747 |
| Free Cash Flow | |||||
| Operating Cash Flow | -65,168 | -86,832 | 8,999 | 213,725 | -1,057 |
| Capital Expenditure | -8,360 | -9,450 | -15,491 | -8,699 | -1,671 |
| Free Cash Flow | -73,528 | -96,282 | -6,492 | 205,026 | -2,728 |